Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Oct 1.

Published in final edited form as: Cancer. 2013 Aug 26;119(19):3454–3461. doi: 10.1002/cncr.28183

Table 3.

Study-directed surgeries

No.	Age at enrollment	CA 125			TVS	Symptoms	Findings at surgery
No.	Age at enrollment	Baseline	Triage to “high risk”	# of annual tests	TVS	Symptoms	Findings at surgery
1	68	29	74	1	Abnormal	No	Stage 1 serous LMP in background of papillary serous adenofibroma
2	64	9	15	6	Abnormal	No	Stage 1 serous LMP
3	63	12	24	2	Abnormal	No	Cystadenoma, mixed mucinous and serous components
4	55	12	22	3	Abnormal	No	Stage IIB high grade serous carcinoma and focal high grade endometrioid carcinoma
5	53	13	18 170	3	#1:Normal #2:Abnormal	GI	Stage IC endometrioid adenocarcinoma and clear cell carcinoma
6	69	75	75	0	Abnormal	No	Serous cystadenofibroma
7	65	19	340	3	Abnormal	No	Stage IC mixed mucinous and endometrioid type with clear cell carcinoma
8	60	45	59	0	Abnormal	No	1^st surgery: no ovarian disease; 2^nd surgery: Stage IB grade 1 endometrial cancer (endometrioid adenocarcinoma)
9	60	13.4	30.5	8	Abnormal	No	Serous cystadenofibroma
10	56	12.82	22.9	6	Abnormal	No	Stage lA high grade serous carcinoma

TVS, transvaginal ultrasound LMP, low malignant potential